Oral Cancer Treatment Market Is Likely to Experience a Strong Growth During 2022-2028
Oral cancer refers to cancer that develops in any part of the mouth, including the tongue, gums, cheeks, and throat. The market for oral cancer treatment is expected to grow significantly in the coming years due to the rising incidence of the disease and increasing research and development activities. The oral cancer treatment market was estimated at US$ 1.8 billion in 2021 and is expected to grow at a CAGR of 5.8% during 2022-2028 to reach US$ ~3.80 billion in 2028.
The treatment of oral cancer typically involves a combination of surgery, radiation therapy, and chemotherapy. Surgery is often the first line of treatment, as it can help remove the cancerous cells and prevent the cancer from spreading to other parts of the body. Radiation therapy is used to kill cancer cells and shrink tumors, while chemotherapy uses drugs to destroy cancer cells throughout the body.
Request a sample here:
https://www.stratviewresearch.com/Request-Sample/3175/oral-cancer-treatment-market.html#form
In recent years, there has been an increasing focus on the development of targeted therapies for oral cancer. These therapies work by targeting specific molecules that are involved in the growth and spread of cancer cells. By targeting these molecules, targeted therapies can be more effective in killing cancer cells while minimizing damage to healthy cells.
One example of a targeted therapy for oral cancer is cetuximab (Erbitux), which is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR). EGFR is a protein that is overexpressed in many types of cancer, including oral cancer. By binding to EGFR, cetuximab can prevent cancer cells from growing and dividing, leading to their death.
Another promising area of research for oral cancer treatment is immunotherapy. Immunotherapy works by stimulating the body's immune system to recognize and attack cancer cells. One example of an immunotherapy for oral cancer is nivolumab (Opdivo), which is a checkpoint inhibitor that blocks the interaction between programmed cell death protein 1 (PD-1) and its ligand, PD-L1. By blocking this interaction, nivolumab can help activate the immune system to attack cancer cells.
The oral cancer treatment market is expected to grow significantly in the coming years, driven by the rising incidence of the disease and increasing research and development activities
The following are the major players in the oral cancer treatment market:
- Bristol-Myers Squibb Company
- Qilu Pharmaceutical Co., Ltd
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- F Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
The oral cancer treatment market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Because of the increased affordability of medications and the increase in incidences of mouth cancer, North America dominates the oral cancer treatment industry. For the forecast period, Asia-Pacific is expected to have the greatest growth rate and CAGR. This is due to rising healthcare infrastructure development costs and rising cigarette consumption.
In conclusion, the oral cancer treatment market is expected to see significant growth in the coming years, driven by the development of targeted therapies and immunotherapies. While surgery, radiation therapy, and chemotherapy will continue to play important roles in the treatment of oral cancer, these new therapies offer the potential for more effective and less toxic treatments. As research in this area continues to advance, we can hope for better outcomes for patients with oral cancer.
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
- Market structure: Overview, industry life cycle analysis, supply chain analysis.
- Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
- Market trend and forecast analysis.
- Market segment trend and forecast.
- Competitive landscape and dynamics: Market share, Product portfolio, New Product Launches, etc.
- Attractive market segments and associated growth opportunities.
- Emerging trends.
- Strategic growth opportunities for the existing and new players.
- Key success factors.